Statins Show Promise in Reducing Death from Ovarian Cancer

Women with ovarian cancer who take statins to lower their cholesterol have a 40% lower death rate.

“These drugs are appealing as they are widely used, inexpensive, and well tolerated in most patients. The associated reduction in ovarian cancer mortality is promising,” said Dr. Kala Visvanathan, lead researcher of a new study presented last week during the American Association for Cancer Research Virtual Annual Meeting II.

Dr. Visvanathan, professor of epidemiology and oncology at Johns Hopkins Bloomberg School of Public Health and Sidney Kimmel Comprehensive Cancer Center in Baltimore, said all statins reduced the risk of dying, with lipophilic statins such as simvastatin and lovastatin, decreasing the likelihood by an average 43%. The most significant reductions occurred in those with high-grade serous carcinoma (40% reduction in mortality) and endometrioid ovarian cancer (50% reduction.)

The findings are the most comprehensive to date and add support to other, smaller studies showing similar improvements in ovarian cancer mortality from statins.

Most recently, a team of researchers at Australia’s QIMR Berghofer Medical Research Institute, analyzed 36 studies of several common medications taken by ovarian cancer patient. They concluded statin use showed the most promise. “Statin use is associated with better ovarian cancer survival,” they wrote in an article this month in Gynecologic Oncology, cautioning that, “Further study, preferably a clinical trial, is required.”

At the AACR meeting, Visvanathan said her team reviewed data on 10,062 ovarian cancer patients from the Finnish national cancer registry. 2,621 used statins, and 80% of those used lipophilic statins.

“Our results provide further evidence in support of the clinical evaluation of lipophilic statins as part of the treatment of ovarian cancer,” Visvanathan said.

Ovarian cancer is a rare cancer type, accounting for only about 1.2% of cancer cases diagnosed in the United States each year. Its five year survival rate is less than 50% because of the difficulty of diagnosing it until it has progressed to an advanced stage.

Is Covid-19 Back or Are We Just Seeing a Surge in Cases?
General Interest Healthcare Pharma

Is Covid-19 Back or Are We Just Seeing a Surge in Cases?

Strategic Networking: A Secret Weapon in Job Searching
Accounting + Finance Architecture + Engineering Financial Services General Interest Healthcare Human Resources Information Technology Legal Support Marketing Technology Pharma Professional Support

Strategic Networking: A Secret Weapon in Job Searching

#WeAreGreenKey: Spotlight on Justin Nadelman
General Interest Green Key News Information Technology Leadership + Management

#WeAreGreenKey: Spotlight on Justin Nadelman

Navigating the Tech Interview Maze: A Guide to Success
General Interest Information Technology

Navigating the Tech Interview Maze: A Guide to Success

Green Key Unlocked: How to Succeed in Payroll Management
Accounting + Finance General Interest Human Resources Leadership + Management

Green Key Unlocked: How to Succeed in Payroll Management

#WeAreGreenKey: Spotlight on Jenny Rehkugler
Accounting + Finance General Interest

#WeAreGreenKey: Spotlight on Jenny Rehkugler

Handling Mistakes & Failure in the Workplace
General Interest Worklife

Handling Mistakes & Failure in the Workplace

How to Support Those Affected by Hawai’i Wildfires 
Green Key News

How to Support Those Affected by Hawai’i Wildfires 

#WeAreGreenKey: Spotlight on Halle Sarfin
Green Key News Professional Support

#WeAreGreenKey: Spotlight on Halle Sarfin

Advantages of Offering Exit Interviews
General Interest Human Resources

Advantages of Offering Exit Interviews

Tracking Metrics: Learning & Development
General Interest Leadership + Management Worklife

Tracking Metrics: Learning & Development

#WeAreGreenKey: Spotlight on Leanna Gallagher
Green Key News Human Resources

#WeAreGreenKey: Spotlight on Leanna Gallagher

How to Beat the Summer Productivity Slump
General Interest Leadership + Management Worklife

How to Beat the Summer Productivity Slump

Questions to Ask When Hiring a Recruiter
General Interest Leadership + Management Worklife

Questions to Ask When Hiring a Recruiter

#WeAreGreenKey: Spotlight on Chianté Vidal
Architecture + Engineering Green Key News

#WeAreGreenKey: Spotlight on Chianté Vidal

Celebrating 10 Years of GKR in Rockville
Green Key News Leadership + Management Professional Support

Celebrating 10 Years of GKR in Rockville

Internal Mobility: Retaining Top Talent
General Interest

Internal Mobility: Retaining Top Talent

Green Key Unlocked: The Future of Telemedicine & Virtual Healthcare
General Interest Healthcare Information Technology

Green Key Unlocked: The Future of Telemedicine & Virtual Healthcare

#WeAreGreenKey: Spotlight on Melissa Sanchez
General Interest Green Key News Healthcare Leadership + Management

#WeAreGreenKey: Spotlight on Melissa Sanchez

#WeAreGreenKey: Spotlight on Rory Valan
General Interest Green Key News Information Technology Worklife

#WeAreGreenKey: Spotlight on Rory Valan

Latest Blog Posts
View All Posts
Is Covid-19 Back or Are We Just Seeing a Surge in Cases?

Is Covid-19 Back or Are We Just Seeing a Surge in Cases?

With the recent increase in hospitalizations and Covid-19 cases across the U.S. the question of How to protect ourselves and...
Read More
Strategic Networking: A Secret Weapon in Job Searching

Strategic Networking: A Secret Weapon in Job Searching

Networking is more than connecting with other professionals on LinkedIn or collecting contacts; it's about building relationships that can lead...
Read More
#WeAreGreenKey: Spotlight on Justin Nadelman

#WeAreGreenKey: Spotlight on Justin Nadelman

Almost seven years since he first joined Green Key, Justin has seized many growth opportunities in his role and truly...
Read More